[01] Overview
The Uptake session will examine how AIMM could be integrated into existing child nutrition, public health, and humanitarian systems. The AIMM team will present the intended users, priority use cases, implementation pathway, and proposed approach to household and community-level monitoring. Participants will assess institutional, regulatory, ethical, financial, and operational barriers to adoption. Particular attention will be given to the evidence required by governments, multilateral organizations, NGOs, and frontline health services before using the technology. The session will identify the most credible pathway for piloting, institutionalization, financing, and responsible scale-up in India and other settings.
DOWNLOAD MEMOWebinar Agenda
[02]
[02]
[02]
5 minutes
Welcome and session objectives
[01] Welcome
10 minutes
Users and priority use cases
[02] Users
15 minutes
Integration into nutrition systems
[03] Systems
[03] Systems
10 minutes
Scale-up and financing pathway
[06] Scale-up
10 minutes
Household and community workflows
[04] Workflows
25 minutes
Facilitated discussion
[07] Discussion
10 minutes
Ethics, regulation, and governance
[05] Governance
[05] Governance
5 minutes
Priorities and next steps
[08] Next Steps
[03] Key Discussion Questions
Which specific user should AIMM be designed around first, and what decision should the tool enable that is not currently possible?
Which specific user should AIMM be designed around first, and what decision should the tool enable that is not currently possible?
Which specific user should AIMM be designed around first, and what decision should the tool enable that is not currently possible?
At which point in an existing nutrition workflow would AIMM add value without duplicating or disrupting established processes?
At which point in an existing nutrition workflow would AIMM add value without duplicating or disrupting established processes?
At which point in an existing nutrition workflow would AIMM add value without duplicating or disrupting established processes?
What minimum evidence on accuracy, safety, usability, and cost would governments or international organizations require before piloting the system?
What minimum evidence on accuracy, safety, usability, and cost would governments or international organizations require before piloting the system?
What minimum evidence on accuracy, safety, usability, and cost would governments or international organizations require before piloting the system?
What are the operational consequences of false-positive and false-negative classifications, and what safeguards are required?
What are the operational consequences of false-positive and false-negative classifications, and what safeguards are required?
What are the operational consequences of false-positive and false-negative classifications, and what safeguards are required?
Should AIMM function primarily as a screening, monitoring, referral, surveillance, or decision-support tool?
Should AIMM function primarily as a screening, monitoring, referral, surveillance, or decision-support tool?
Should AIMM function primarily as a screening, monitoring, referral, surveillance, or decision-support tool?
What data-governance, consent, privacy, and child-protection requirements must be met for household and community use?
What data-governance, consent, privacy, and child-protection requirements must be met for household and community use?
What incentives, training, supervision, connectivity, and maintenance would be required for sustained use by households or frontline workers?
What incentives, training, supervision, connectivity, and maintenance would be required for sustained use by households or frontline workers?
Which procurement, financing, ownership, and institutional arrangements would offer the most realistic pathway to scale?
Which procurement, financing, ownership, and institutional arrangements would offer the most realistic pathway to scale?
[01] Overview
The Uptake session will examine how AIMM could be integrated into existing child nutrition, public health, and humanitarian systems. The AIMM team will present the intended users, priority use cases, implementation pathway, and proposed approach to household and community-level monitoring. Participants will assess institutional, regulatory, ethical, financial, and operational barriers to adoption. Particular attention will be given to the evidence required by governments, multilateral organizations, NGOs, and frontline health services before using the technology. The session will identify the most credible pathway for piloting, institutionalization, financing, and responsible scale-up in India and other settings.
Webinar Agenda
[02]
[02]
[02]
5 minutes
Welcome and session objectives
[01] Welcome
10 minutes
Users and priority use cases
[02] Users
15 minutes
Integration into nutrition systems
[03] Systems
[03] Systems
10 minutes
Scale-up and financing pathway
[06] Scale-up
10 minutes
Household and community workflows
[04] Workflows
25 minutes
Facilitated discussion
[07] Discussion
10 minutes
Ethics, regulation, and governance
[05] Governance
[05] Governance
5 minutes
Priorities and next steps
[08] Next Steps
[03] Key Discussion Questions
Which specific user should AIMM be designed around first, and what decision should the tool enable that is not currently possible?
Which specific user should AIMM be designed around first, and what decision should the tool enable that is not currently possible?
Which specific user should AIMM be designed around first, and what decision should the tool enable that is not currently possible?
At which point in an existing nutrition workflow would AIMM add value without duplicating or disrupting established processes?
At which point in an existing nutrition workflow would AIMM add value without duplicating or disrupting established processes?
At which point in an existing nutrition workflow would AIMM add value without duplicating or disrupting established processes?
What minimum evidence on accuracy, safety, usability, and cost would governments or international organizations require before piloting the system?
What minimum evidence on accuracy, safety, usability, and cost would governments or international organizations require before piloting the system?
What minimum evidence on accuracy, safety, usability, and cost would governments or international organizations require before piloting the system?
What are the operational consequences of false-positive and false-negative classifications, and what safeguards are required?
What are the operational consequences of false-positive and false-negative classifications, and what safeguards are required?
What are the operational consequences of false-positive and false-negative classifications, and what safeguards are required?
Should AIMM function primarily as a screening, monitoring, referral, surveillance, or decision-support tool?
Should AIMM function primarily as a screening, monitoring, referral, surveillance, or decision-support tool?
Should AIMM function primarily as a screening, monitoring, referral, surveillance, or decision-support tool?
What data-governance, consent, privacy, and child-protection requirements must be met for household and community use?
What data-governance, consent, privacy, and child-protection requirements must be met for household and community use?
What incentives, training, supervision, connectivity, and maintenance would be required for sustained use by households or frontline workers?
What incentives, training, supervision, connectivity, and maintenance would be required for sustained use by households or frontline workers?
Which procurement, financing, ownership, and institutional arrangements would offer the most realistic pathway to scale?
Which procurement, financing, ownership, and institutional arrangements would offer the most realistic pathway to scale?
[01] Overview
The Uptake session will examine how AIMM could be integrated into existing child nutrition, public health, and humanitarian systems. The AIMM team will present the intended users, priority use cases, implementation pathway, and proposed approach to household and community-level monitoring. Participants will assess institutional, regulatory, ethical, financial, and operational barriers to adoption. Particular attention will be given to the evidence required by governments, multilateral organizations, NGOs, and frontline health services before using the technology. The session will identify the most credible pathway for piloting, institutionalization, financing, and responsible scale-up in India and other settings.
Webinar Agenda
[02]
[02]
[02]
5 minutes
Welcome and session objectives
[01] Welcome
10 minutes
Users and priority use cases
[02] Users
15 minutes
Integration into nutrition systems
[03] Systems
[03] Systems
10 minutes
Scale-up and financing pathway
[06] Scale-up
10 minutes
Household and community workflows
[04] Workflows
25 minutes
Facilitated discussion
[07] Discussion
10 minutes
Ethics, regulation, and governance
[05] Governance
[05] Governance
5 minutes
Priorities and next steps
[08] Next Steps
[03] Key Discussion Questions
Which specific user should AIMM be designed around first, and what decision should the tool enable that is not currently possible?
Which specific user should AIMM be designed around first, and what decision should the tool enable that is not currently possible?
Which specific user should AIMM be designed around first, and what decision should the tool enable that is not currently possible?
At which point in an existing nutrition workflow would AIMM add value without duplicating or disrupting established processes?
At which point in an existing nutrition workflow would AIMM add value without duplicating or disrupting established processes?
At which point in an existing nutrition workflow would AIMM add value without duplicating or disrupting established processes?
What minimum evidence on accuracy, safety, usability, and cost would governments or international organizations require before piloting the system?
What minimum evidence on accuracy, safety, usability, and cost would governments or international organizations require before piloting the system?
What minimum evidence on accuracy, safety, usability, and cost would governments or international organizations require before piloting the system?
What are the operational consequences of false-positive and false-negative classifications, and what safeguards are required?
What are the operational consequences of false-positive and false-negative classifications, and what safeguards are required?
What are the operational consequences of false-positive and false-negative classifications, and what safeguards are required?
Should AIMM function primarily as a screening, monitoring, referral, surveillance, or decision-support tool?
Should AIMM function primarily as a screening, monitoring, referral, surveillance, or decision-support tool?
Should AIMM function primarily as a screening, monitoring, referral, surveillance, or decision-support tool?
What data-governance, consent, privacy, and child-protection requirements must be met for household and community use?
What data-governance, consent, privacy, and child-protection requirements must be met for household and community use?
What incentives, training, supervision, connectivity, and maintenance would be required for sustained use by households or frontline workers?
What incentives, training, supervision, connectivity, and maintenance would be required for sustained use by households or frontline workers?
Which procurement, financing, ownership, and institutional arrangements would offer the most realistic pathway to scale?
Which procurement, financing, ownership, and institutional arrangements would offer the most realistic pathway to scale?